When optimally managed, the relationship between pharmaceutical organizations and healthcare professionals (HCPs) on the frontlines of patient care is bi-directional. With the right tools, pharma companies can collect feedback from external stakeholders, like HCPs, to help with clinical decision-making.
A leading pharmaceutical organization’s joint medical affairs and commercial team, purposed with gaining insight and treatment perspectives about prescribing preferences and informational needs, was tasked with identifying an innovative approach to facilitating bi-directional discussions with leading clinicians around the country.
This case study explains how they did it.
It was far more efficient and avoids the potential challenge that one or some individuals might dominate the conversation. This seemed to be a more egalitarian approach to hearing all voices. Finally, it provided us time to consider our answers.Virtual Meeting Clinician Participant